In a study of glioblastoma, high levels of LSP1 are accompanied by elevated immune infiltration that favours the immunosuppressive TME and poor response to radio/chemotherapy, suggesting that LSP1 might serve as a progressive malignancy marker25. This evidence concerns the gene LSP1 and glioblastoma.